| Pharmaceutical Information |
| Drug Name |
Cefiderocol |
| Drug ID |
BADD_D02541 |
| Description |
Cefiderocol is a cephalosporin antibacterial drug and exerts a mechanism of action similar to other β-lactam antibiotics.[FDA Label] Unlike other agents in this category, cefiderocol is a siderophore able to undergo active transport into the bacterial cell through iron channels.[A189057] It represents a significant addition to antibacterial treatment option as it has proven to be effective *in vitro* against multidrug resistant strains including extended spectrum β-lactamase producers and carbapenemase producing bacteria.
Cefiderocol was granted designation as a Qualified Infectious Disease Product and granted priority review status by the FDA on November 14, 2019.[L10893] It is indicated for use in complicated urinary tract infections in patients with limited or no alternative treatments available.[FDA Label] This indication was supported by a positive clinical trial composed of 448 patients with complicated urinary tract infections which demonstrated a 72.6% rate of symptom resolution and bacterial eradication with cefiderocol compared to 54.6% with the comparator, imipenem/cilastatin.[A189150] A concern noted in the trial was a 0.3% higher rate of all cause mortality, the cause of which has not been determined. |
| Indications and Usage |
Cefiderocol is indicated for the treatment of complicated urinary tract infections with or without pyelonephritis.[FDA Label] |
| Marketing Status |
approved; investigational |
| ATC Code |
J01DI04 |
| DrugBank ID |
DB14879
|
| KEGG ID |
D11302
|
| MeSH ID |
C000612166
|
| PubChem ID |
77843966
|
| TTD Drug ID |
D0Q7MA
|
| NDC Product Code |
Not Available |
| UNII |
SZ34OMG6E8
|
| Synonyms |
cefiderocol | S-649266 |
|
| Chemical Information |
| Molecular Formula |
C30H34ClN7O10S2 |
| CAS Registry Number |
1225208-94-5 |
| SMILES |
CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5
=C(C(=C(C=C5)O)O)Cl)C(=O)[O-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
